hotspot -WSS

hotspot

author：knowledge 2025-09-30 00:48:25 - browse：652

Illustration of a hospital being handed from a doctor to a business person – politics and policy coverage from STAT — New guidelines from federal antitrust enforcers would have big implications on health care deals. Adobe

Health care companies trying to merge can expect tougher policing from the top federal antitrust agencies, according to a set of new draft guidelines released Wednesday.

The Department of Justice and Federal Trade Commission laid out 13 proposed guidelines detailing how they will judge whether proposed mergers and acquisitions are anticompetitive and should be challenged.

The rules would apply broadly across the economy, but they have strong implications for the health care industry, where sizable deals among hospitals, physician practices, private equity firms, health insurers, pharmacy benefit managers, pharmaceutical companies, medical device firms, and numerous other entities occur almost weekly. Research has shown that health care’s highly concentrated markets are a major reason why prices and spending have soared for patients and taxpayers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Readout Newsletter: The latest on Novavax, Merck, Bluebird

focus

WSS

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

White House pharmacy plagued with problems, investigation finds

CDC director unscathed in first congressional testimony

Medicare Advantage insurers face 0.2% cut to 2025 payments

Despite FDA concern, risk that CAR

Bernie Sanders is gearing up to subpoena pharma CEOs

focus

hotspot

hotspot

At least 13 dead in Texas as scorching temps continue

Pediatric cancer treatments threatened by a new FDA policy

Cancer drug shortages should be causing more outrage

10 reasons why health care startups fail

23andMe had bad news about my health. I wish a person had delivered it

BIO selects John Crowley as new CEO

Drug repurposing or repositioning? The language matters

The Affordable Care Act has saved billions in health care costs

In age of alternative facts, a scholarly course on calling out crap

Reconstructing family trees of blood cells may help predict disease

focus

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

FTC sues over Novant Health acquisition of two N.C. hospitals

BIO selects John Crowley as new CEO

Rep. Raul Ruiz on the physician shortage and more

Disappointing trial forces Pfizer to pivot on obesity medicine plans

focus

focus

focus

entertainment